Advertisement
U.S. Markets open in 7 hrs 7 mins
S&P Futures
5,886.50 -0.50 (-0.01%) Dow Futures
43,302.00 -40.00 (-0.09%) Nasdaq Futures
20,384.50 +35.00 (+0.17%) Russell 2000 Futures
2,306.00 +1.60 (+0.07%) Crude Oil
70.54 +0.15 (+0.21%) Gold
2,697.00 +5.70 (+0.21%)
argenx SE (ARGNF)
OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
Follow
At close: 04:00PM EDT
| Previous Close | 540.00 |
| Open | 540.00 |
| Bid | 525.00 x 2900 |
| Ask | 572.90 x 1400 |
| Day's Range | 540.00 - 540.00 |
| 52 Week Range | 341.00 - 540.00 |
| Volume | |
| Avg. Volume | 3 |
| Market Cap | 32.481B |
| Beta (5Y Monthly) | 0.31 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.52 |
| Earnings Date | Oct 31, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Insider MonkeyMultiple Tailwinds Lifted argenx SE (ARGX) in Q3
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. In the third quarter, the fund’s Investor Class fund ARTMX returned 2.35%, Advisor Class fund APDMX posted a return of 2.38%, and Institutional Class fund APHMX returned 2.40%, compared […]
- MT Newswires
Argenx Says New Data on its Generalized Myasthenia Gravis Treatments Demonstrate 'Sustained Responses'
Argenx Says New Data on its Generalized Myasthenia Gravis Treatments Demonstrate 'Sustained Responses'
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.